Kurt Schrader sold Nutrien Ltd (NYSE: NTR)
Kurt Schrader (D-OR), a U.S. Representative, has disclosed 1 trade in Nutrien Ltd (NTR) since 2022, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kurt Schrader sold $1,001 - $15,000 of Nutrien Ltd (NYSE: NTR) on March 17, 2022. Since that trade, NTR is down -16.66% against the S&P 500 up +78.26%, an outperformance of -94.92%.
Data updated
Kurt Schrader's NTR trades vs the price
NTR is down -16.66% since Kurt Schrader sold on March 17, 2022, versus +78.26% for the S&P 500.
Performance since this trade
All Kurt Schrader NTR trades
Kurt Schrader & NTR trading FAQ
Is it legal for Kurt Schrader to trade Nutrien Ltd (NTR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Nutrien Ltd (NTR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kurt Schrader sell NTR?
Kurt Schrader disclosed a sale of $1,001 - $15,000 of Nutrien Ltd (NTR) on March 17, 2022, according to public STOCK Act filings.
How has NTR performed since Kurt Schrader's trade?
Since Kurt Schrader sold NTR on March 17, 2022, the stock is down -16.66%, versus +78.26% for the S&P 500 over the same period, an outperformance of -94.92%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NTR trades?
Quantellect tracks every disclosed congressional trade in Nutrien Ltd (NTR) on the Nutrien Ltd congressional trading page, which aggregates filings across all members of Congress.
Kurt Schrader's NTR tradesAll congressional filings for Nutrien LtdKurt Schrader's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.